IGC Pharma, Inc. (IGC): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Not updated since 2025-03-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2018-03-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$618.0K
Year ended 2025-03-31
$571.0K
Trailing 12 months to 2025-09-30
-1.7%
3-year compound annual growth
+33.8%
5-year compound annual growth
$996.4K2011-03-31: $785.1K2012-03-31: $996.4K2013-03-31: $673.9K2014-03-31: $712.3K2015-03-31: $781.5K2016-03-31: $728.7K2017-03-31: $396.3K2018-03-31: $19.0K2019-03-31: $59.0K2020-03-31: $144.0K2021-03-31: $478.0K2022-03-31: $651.0K2023-03-31: $657.0K2024-03-31: $637.0K2025-03-31: $618.0K$618.0K
2011-03-31 Depreciation & Amortization (USD) 2025-03-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-03-31$618.0K-3.0%2025-06-27, From 2024-04-01
2024-03-31$637.0K-3.0%2025-06-27, From 2023-04-01
2023-03-31$657.0K+0.9%2024-06-24, From 2022-04-01
2022-03-31$651.0K+36.2%2023-07-07, From 2021-04-01
2021-03-31$478.0K+231.9%2022-06-23, From 2020-04-01
2020-03-31$144.0K+144.1%2021-06-14, From 2019-04-01
2019-03-31$59.0K+210.5%2020-07-13, From 2018-04-01
2018-03-31$19.0Kn/c2019-06-14, From 2017-04-01
2017-03-31$396.3K-45.6%2018-06-21, From 2016-04-01
2016-03-31$728.7K-6.8%2017-07-14, From 2015-04-01
2015-03-31$781.5K+9.7%2016-07-14, From 2014-04-01
2014-03-31$712.3K+5.7%2015-07-14, From 2013-04-01
2013-03-31$673.9K-32.4%2014-07-15, From 2012-04-01
2012-03-31$996.4K+26.9%2014-07-15, From 2011-04-01
2011-03-31$785.1Kn/a2012-07-16, From 2010-04-01